[go: up one dir, main page]

PT1159279E - 4-oxo-4,7-di-hidrotieno¬2,3-b|piridino-5-carboxamidas como agentes antivirais - Google Patents

4-oxo-4,7-di-hidrotieno¬2,3-b|piridino-5-carboxamidas como agentes antivirais

Info

Publication number
PT1159279E
PT1159279E PT00913786T PT00913786T PT1159279E PT 1159279 E PT1159279 E PT 1159279E PT 00913786 T PT00913786 T PT 00913786T PT 00913786 T PT00913786 T PT 00913786T PT 1159279 E PT1159279 E PT 1159279E
Authority
PT
Portugal
Prior art keywords
dihydrotiene
carboxamides
oxo
pyridine
antiviral agents
Prior art date
Application number
PT00913786T
Other languages
English (en)
Inventor
Mark E Schnute
Michele M Cudahy
Allen Scott
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of PT1159279E publication Critical patent/PT1159279E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
PT00913786T 1999-03-09 2000-03-07 4-oxo-4,7-di-hidrotieno¬2,3-b|piridino-5-carboxamidas como agentes antivirais PT1159279E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12366099P 1999-03-09 1999-03-09

Publications (1)

Publication Number Publication Date
PT1159279E true PT1159279E (pt) 2003-02-28

Family

ID=22410054

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00913786T PT1159279E (pt) 1999-03-09 2000-03-07 4-oxo-4,7-di-hidrotieno¬2,3-b|piridino-5-carboxamidas como agentes antivirais

Country Status (25)

Country Link
US (2) US6239142B1 (pt)
EP (1) EP1159279B1 (pt)
JP (1) JP2002539130A (pt)
KR (1) KR20010102543A (pt)
CN (1) CN1347417A (pt)
AT (1) ATE226208T1 (pt)
AU (1) AU759875B2 (pt)
BR (1) BR0008804A (pt)
CA (1) CA2366609A1 (pt)
CZ (1) CZ20013028A3 (pt)
DE (1) DE60000611T2 (pt)
DK (1) DK1159279T3 (pt)
EA (1) EA003607B1 (pt)
ES (1) ES2184705T3 (pt)
HK (1) HK1045518A1 (pt)
HU (1) HUP0200324A3 (pt)
IL (1) IL145005A0 (pt)
NO (1) NO20014363L (pt)
NZ (1) NZ513758A (pt)
PL (1) PL350651A1 (pt)
PT (1) PT1159279E (pt)
SK (1) SK12582001A3 (pt)
TW (1) TWI222451B (pt)
WO (1) WO2000053610A2 (pt)
ZA (1) ZA200107255B (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730682B2 (en) 2000-07-12 2004-05-04 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
US6559145B2 (en) 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
US6562822B2 (en) 2000-07-12 2003-05-13 Pharmacia & Upjohn Company Heterocyle carboxamides as antiviral agents
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
US7638522B2 (en) 2001-08-13 2009-12-29 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
US8101629B2 (en) 2001-08-13 2012-01-24 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
JP2005502685A (ja) * 2001-08-30 2005-01-27 ファルマシア・アンド・アップジョン・カンパニー 抗ウイルス剤としての4−チオキソ−4,7−ジヒドロ−チエノ[2,3−b]ピリジン−5−カルボキシアミド
WO2003020728A1 (en) * 2001-08-30 2003-03-13 Pharmacia & Upjohn Company 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS
BR0215080A (pt) * 2001-12-20 2004-10-05 Osi Pharm Inc Composto inibidores de lipase pancreática, sua sìntese e uso
AR038117A1 (es) * 2002-01-14 2004-12-29 Upjohn Co Agentes antivirales derivados de la 4- oxo-4,7 -dihidrofuro [2,3-b]piridin-5-carboxamida
AR038118A1 (es) 2002-01-14 2004-12-29 Upjohn Co Compuestos derivados de la bencinamida del acido 7-oxo-4,7-dihidrotien[2,3-b[piridin-6-carboxilico 3-sustituido que son utiles como antivirales
AR038294A1 (es) * 2002-01-14 2005-01-12 Upjohn Co Oxotieno(3,2-b)piridincarboxamidas como agentes antivirales
AU2003222077A1 (en) * 2002-04-22 2003-11-03 Pharmacia And Upjohn Company A trifluoroacetic acid process to prepare (2,3-b)pyridine intermediates
ES2422196T3 (es) 2002-08-09 2013-09-09 Janssen Pharmaceutica Nv Procesos para la preparación de 4-4-4-(2-cianoetenil)-2,6-dimetilfenil)amino)-2-pirimidinil)aminobenzonitrilo
WO2004019940A1 (en) * 2002-08-30 2004-03-11 Pharmacia & Upjohn Company Method of preventing or treating atherosclerosis or restenosis
US20040102473A1 (en) * 2002-08-30 2004-05-27 Wathen Michael W. Method of preventing or treating atherosclerosis or restenosis
WO2004019932A1 (en) * 2002-08-30 2004-03-11 Pharmacia & Upjohn Company Method of preventing or treating atherosclerosis or restenosis
AU2003262946A1 (en) * 2002-08-30 2004-03-19 Pharmacia And Upjohn Company Method of preventing or treating atherosclerosis or restenosis
AU2003269950A1 (en) * 2002-09-04 2004-03-29 Pharmacia & Upjohn Company Llc Heteroaryl-ethanolamine derivatives as antiviral agents
WO2004022566A1 (en) * 2002-09-04 2004-03-18 Pharmacia & Upjohn Company Llc 4-OXO-4,7-DIHYDROTHIENO[2,3-b]PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS
US20040116464A1 (en) * 2002-09-04 2004-06-17 Schnute Mark E. Aryl-ethanolamine derivatives as antiviral agents
AU2003304151A1 (en) * 2002-09-04 2005-01-21 Pharmacia And Upjohn Company Heteroaryl-ethanolamine derivatives as antiviral agents
WO2005003140A1 (en) * 2003-07-02 2005-01-13 Pharmacia & Upjohn Company Llc 4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents
US20070208015A1 (en) * 2004-04-13 2007-09-06 Astex Therapeutics, Ltd. 5-Morpholinylmethylthiophenyl Pharmaceutical Compounds As P38 MAP Kinase Modulators
SE0401578D0 (sv) 2004-06-18 2004-06-18 Active Biotech Ab Novel compounds
WO2006093518A2 (en) * 2004-06-25 2006-09-08 Apath, Llc Thienyl compounds for treating virus-related conditions
WO2010099166A1 (en) * 2009-02-27 2010-09-02 Siga Technologies, Inc. Thienopyridine derivatives for the treatment and prevention of dengue virus infections
MX385975B (es) 2016-02-16 2025-03-18 Univ Vanderbilt Moduladores alostéricos positivos del receptor de acetilcolina muscarínico m1.
US10899759B2 (en) 2016-09-30 2021-01-26 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor M1
CN112996789A (zh) 2018-09-12 2021-06-18 诺华股份有限公司 抗病毒吡啶并吡嗪二酮化合物
AU2020353055B2 (en) 2019-09-26 2024-03-07 Gilead Sciences, Inc. Antiviral pyrazolopyridinone compounds
CN115073489B (zh) * 2021-03-15 2023-11-28 同济大学 一种噻吩骈吡啶酮类化合物、制备方法及一种抗真菌药物
EP4313995A4 (en) * 2021-04-14 2025-02-26 University of Virginia Patent Foundation COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING LUNG INJURY

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5268193A (en) 1975-11-28 1977-06-06 Sumitomo Chem Co Ltd Synthesis of novel cephalosporin derivatives
US4145418A (en) 1976-01-06 1979-03-20 Takeda Chemical Industries, Ltd. Thienopyridine substituted cephalosporins
US4568649A (en) 1983-02-22 1986-02-04 Immunex Corporation Immediate ligand detection assay
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4767766A (en) 1987-01-30 1988-08-30 Merck & Co., Inc. Derivatives of 3-hydroxyazabenzo(B)thiophene useful as 5-lipoxygenase inhibitors
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US4959363A (en) * 1989-06-23 1990-09-25 Sterling Drug Inc. Quinolonecarboxamide compounds, their preparation and use as antivirals.
CA2036618C (en) * 1990-02-22 2002-10-29 Akira Morimoto Fused thiophene derivatives, their production and use
WO1992003427A1 (fr) 1990-08-17 1992-03-05 Yoshitomi Pharmaceutical Industries, Ltd. Compose de cetone et remede pour l'osteoporose
US5219864A (en) 1991-03-12 1993-06-15 Kyowa Hakko Kogyo Co., Ltd. Thienopyridine derivatives
DE4227747A1 (de) 1992-08-21 1994-02-24 Basf Ag Heteroaromatisch kondensierte Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung
JPH0776586A (ja) 1993-07-16 1995-03-20 Yoshitomi Pharmaceut Ind Ltd ピリジン化合物
TW449600B (en) 1994-04-19 2001-08-11 Takeda Chemical Industries Ltd Condensed-ring thiophene derivatives, their production and use
AU4515896A (en) 1994-12-12 1996-07-03 Merck & Co., Inc. Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
AU4515696A (en) 1994-12-12 1996-07-03 Merck & Co., Inc. Substituted 2-aminopyridines as inhibitors of nitric oxide synthase
JPH08301849A (ja) 1995-05-01 1996-11-19 Takeda Chem Ind Ltd ヘテロ環化合物およびその製造法
JPH09208496A (ja) 1996-01-30 1997-08-12 Takeda Chem Ind Ltd Lh−rh拮抗物質含有組成物
WO1997040846A1 (en) 1996-04-30 1997-11-06 Takeda Chemical Industries, Ltd. COMBINED USE OF GnRH AGONIST AND ANTAGONIST
CA2262786A1 (en) 1996-09-10 1998-03-19 Pharmacia & Upjohn Company 8-hydroxy-7-substituted quinolines as anti-viral agents
KR20010052570A (ko) 1998-06-04 2001-06-25 스티븐 에프. 웨인스톡 세포 유착을 억제하는 소염성 화합물

Also Published As

Publication number Publication date
ES2184705T3 (es) 2003-04-16
EA200100955A1 (ru) 2002-02-28
NZ513758A (en) 2001-09-28
US6495683B2 (en) 2002-12-17
DE60000611D1 (en) 2002-11-21
US20020006937A1 (en) 2002-01-17
CZ20013028A3 (cs) 2002-03-13
PL350651A1 (en) 2003-01-27
IL145005A0 (en) 2002-06-30
EA003607B1 (ru) 2003-06-26
TWI222451B (en) 2004-10-21
NO20014363L (no) 2001-11-08
HK1045518A1 (zh) 2002-11-29
WO2000053610A3 (en) 2001-01-25
AU3516200A (en) 2000-09-28
WO2000053610A2 (en) 2000-09-14
ATE226208T1 (de) 2002-11-15
HUP0200324A3 (en) 2003-07-28
US6239142B1 (en) 2001-05-29
KR20010102543A (ko) 2001-11-15
CN1347417A (zh) 2002-05-01
AU759875B2 (en) 2003-05-01
BR0008804A (pt) 2002-04-16
EP1159279A2 (en) 2001-12-05
HUP0200324A2 (en) 2002-06-29
NO20014363D0 (no) 2001-09-07
JP2002539130A (ja) 2002-11-19
ZA200107255B (en) 2002-12-02
DE60000611T2 (de) 2003-06-26
DK1159279T3 (da) 2003-02-17
SK12582001A3 (sk) 2002-02-05
CA2366609A1 (en) 2000-09-14
EP1159279B1 (en) 2002-10-16

Similar Documents

Publication Publication Date Title
PT1159279E (pt) 4-oxo-4,7-di-hidrotieno¬2,3-b|piridino-5-carboxamidas como agentes antivirais
AP1753A (en) Thiophene derivatives as antiviral agents for flavvivirus infection
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
SE9903760D0 (sv) New compounds
WO2001019829A3 (en) Pyrazolopyrimidines as therapeutic agents
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
SE9900100D0 (sv) New compounds
AU2002246728A1 (en) Carboline derivatives
TR200201205T2 (tr) N-ikame edilmiş karbamoiloksialkil-azolyum türevleri.
ATE339409T1 (de) Trizyklische verbindungen
AU2002213421A1 (en) Condensed pyridoindole derivatives
AU2002249890A1 (en) Carboline derivatives
NO20055510L (no) 2-alkynyl- og 2-alkenylpyrazolo [4,3-E]-1,2,4-triazolo-[1,5-C]-pyrimidin-adenosin A2A-reseptorantagonister
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
WO2003059878A3 (en) Thieno (3, 2-b) pyridones as antiviral compounds
MXPA04006041A (es) Antivirales de piridoquinoxalina.
MXPA04000407A (es) Derivados de fenilacetamido-tiazol, procedimiento para su preparacion y uso como agentes antitumorales.
EP1453506A4 (en) Topoisomerase GIFT FUNDS
PT1204658E (pt) Agonistas benzofurilpiperazina de serotonina
WO2003059911A3 (en) 4-OXO-4, 7-DIHYDROFURO[2,3-b]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS
MXPA03012039A (es) Derivados de benzo [g]quinolina para tratar glaucoma y miopia.
BR0211214A (pt) 4-tioxo-4,7-dihidro-tieno [2,3-b]piridina-5-carboxamidas como agentes antivirais
BR0211557A (pt) Compostos de 4-tioxo-4,7-dihidro-tieno[2,3-b]piridina-5-carbotioamid as como agentes antivirais, contosições e seus usos
MX9804828A (es) Benzotiazolona etanaminas biologicamente activas.
SE0102058D0 (sv) New Salts II